Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OncoMed Pharmaceuticals Inc (NASDAQ:OMED)

4.81
Delayed Data
As of Nov 20
 -0.40 / -7.68%
Today’s Change
2.91
Today|||52-Week Range
10.89
-37.61%
Year-to-Date
No recent news for OncoMed Pharmaceuticals Inc.

Today’s Trading

Previous close5.21
Today’s open5.23
Day’s range4.77 - 5.47
Volume134,008
Average volume (3 months)172,809
Market cap$182.1M
Dividend yield--
Data as of 4:00pm ET, 11/20/2017

Growth & Valuation

Earnings growth (last year)-10.56%
Earnings growth (this year)+48.82%
Earnings growth (next 5 years)--
Revenue growth (last year)-2.88%
P/E ratioNM
Price/Sales10.07
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SBPHSpring Bank Pharmace...-1.12-7.16%
MNOVMediciNova Inc+0.25+3.82%
CKPTCheckpoint Therapeut...+0.03+0.70%
OCULOcular Therapeutix I...-0.29-5.84%
Data as of 4:00pm ET, 11/20/2017

Financials

Next reporting dateMarch 8, 2018
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$25.2M
Annual profit (last year)-$103.1M
Net profit margin-409.90%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Paul J. Hastings
CFO, EV President-Corporate Development &
Finance
Sunil Patel
Corporate headquarters
Redwood City, California

Forecasts